<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fanconi <z:hpo ids='HP_0001903'>anemia</z:hpo> (FA) is a rare <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo> or <z:hpo ids='HP_0001417'>X-linked</z:hpo> disorder characterized by <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> susceptibility and cellular sensitivity to DNA crosslinking agents </plain></SENT>
<SENT sid="1" pm="."><plain>Eight FA proteins (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL and FANCM) and three non-FA proteins (FAAP100, FAAP24 and HES1) form an FA nuclear core complex, which is required for monoubiquitination of the FANCD2-FANCI dimer upon DNA damage </plain></SENT>
<SENT sid="2" pm="."><plain>FANCL possesses a PHD/RING-finger domain and is a putative E3 ubiquitin ligase subunit of the core complex </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, we report an FA patient with an unusual presentation belonging to the FA-L complementation group </plain></SENT>
<SENT sid="4" pm="."><plain>The patient lacks an obvious FA phenotype except for the presence of a caf√©-au-lait spot, mild hypocellularity and a family history of <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The molecular diagnosis and identification of the FA subgroup was achieved by FA complementation assay </plain></SENT>
<SENT sid="6" pm="."><plain>We identified bi-allelic novel mutations in the FANCL gene and functionally characterized them </plain></SENT>
<SENT sid="7" pm="."><plain>To the best of our knowledge, this is the second reported case belonging to the FA-L complementation group </plain></SENT>
</text></document>